[68Ga]-neoB
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68Ga]-neoB, covering 2026-01-28 to 2026-01-28. Get the full timeline:
Most recent: Clinical Trial Update: [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake [Phase 1, Phase 2]